MaxCyte (MXCT) has a debt-to-equity ratio of 0.12, below the Materials sector average of 0.33.
Get informed when a big investor buys or sells
+ Follow0.12
Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.
The latest debt-to-equity ratio for MXCT is 0.12. That is below the Materials sector average of 0.33. Investors often review this figure alongside MaxCyte's historical trend and sector peers before judging valuation or financial health.
Against Materials companies, MXCT currently prints 0.12 for debt-to-equity ratio, while the sector average sits near 0.33. That is roughly 63.0% below the sector mean. Large gaps often invite a closer look at MaxCyte's growth, margins, and balance sheet.
A debt-to-equity ratio of 0.12 for MaxCyte is not 'good' or 'bad' on its own. Compare it with the peer average (0.33) and with MXCT's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting MXCT's debt-to-equity ratio (0.12), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack MaxCyte's debt-to-equity ratio against similar Materials names. You can also browse sector and industry screens on Stockcircle for a broader set of Materials companies and their key multiples and fundamentals.